Skip to main content

Table 3 Proportion of patients with serum creatinine elevation > 1.5 times that at baseline

From: Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin

Day

% Patients with serum creatinine elevation > 1.5

P-Value

Electrolyte Supplementation Arm % (n)

Non-electrolyte Arm % (n)

Day 7

6.1 (48)

30.2 (43)

0.0025

Day 14

8.9 (45)

36.6 (41)

0.002

Day 21

2.3 (43)

43.9 (41)

< 0.0001

Day 28

0 (27)

24 (25)

0.0068